Prognostic factors affecting the survival of patients with brain metastasis treated by whole brain radiotherapy: A regional cancer center experience from North West India
Peptide receptor radionuclide therapy with lutetium-177 DOTATATE in a case of recurrent extradrenal retroperitoneal malignant paraganglioma with nodal and bone metastasis